Gut microbiome and CAR-T therapy

Abstract Considerable progress has been made in cancer therapeutics recently with targeted strategies that are efficacious and less toxic. Immunotherapy and chimeric antigen receptor (CAR) T-cells are increasingly being evaluated in a variety of tumors in the relapsed/refractory as well as frontline...

Full description

Bibliographic Details
Published in:Experimental Hematology & Oncology
Main Authors: Muhammad Bilal Abid, Nirav N. Shah, Theresa C. Maatman, Parameswaran N. Hari
Format: Article
Language:English
Published: BMC 2019-11-01
Subjects:
Immunotherapy
Immuno-oncology
CAR T-cells
TRUCKs
Gut microbiome
Dysbiosis
Online Access:http://link.springer.com/article/10.1186/s40164-019-0155-8

Internet

http://link.springer.com/article/10.1186/s40164-019-0155-8

Similar Items